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Summary 
Recently, four genes (TAP1, TAP2, LMP2, LMP7) involved or potentially involved in the pro- 
cessing and transport of major histocompatibility complex class I-associated antigen to the en- 
doplasmic reticulum have been identified. We now report the initial characterization of the bi- 
directional promoter for the human transporter associated with antigen processing 1 (TAP1) 
and low molecular mass polypeptide 2 (LMP2) genes. These genes are divergently transcribed 
from a central promoter region of only 593 bp. Functional analysis using a bidirectional reporter 
system demonstrates the minimal 593-bp promoter is sufficient for concurrent expression in both 
directions. There is no TATA box homology at either end but there is a prevalence of GC boxes. 
Transcription is initiated at multiple sites for each gene without any of the TAP1 transcripts 
overlapping with the LMP2 transcripts. The region proximal to the TAP1 gene is required for 
maximal basal level expression of not only TAP1 but also LMP2. Furthermore, this region is 
necessary for tumor necrosis factor oe (TNF-oe) induction of both genes. Site-specific mutations 
of an NF-t~B element in the TAP1 proximal region blocked induction by TNF-cx in both the 
TAP1 and LMP2 directions. An adjacent GC box was required for basal expression of both genes 
as well as augmenting the TNF-oe induction of the distal LMP2 gene. In vivo genomic foot- 
printing of this region revealed strong protein/DNA interactions at the NF-KB and GC box 
consensus sequences. In vitro binding studies confirmed the capacity of the NF-KB site to bind 
p50/p65 and p52/p65 heterodimers and of the GC box to bind Spl. Thus, the promoter elements 
proximal to the TAP1 gene play a significant role in regulating basal and induced expression 
of both TAP1 and LMP2. The findings presented in this report clearly link LMP2 expression 
with TAP1 expression and provide additional suggestive evidence linking LMP2 to class I an- 
tigen presentation. 
p resentation of antigenic peptide in the context of MHC class I molecules is required for the intrathymic 
selection and development of CD8 + T cells (1, 2) and for 
cytotoxic T cell-mediated killing of infected or transformed 
cells (3-5). The regulation of class I heavy chain expression 
on the cell surface occurs at multiple levels, including the 
retention of empty class I molecules in the endoplasmic retic- 
ulum (ER) 1 until association with both/$2-microglobulin 
The first two authors contributed equally to this work and should both 
be considered first authors. 
1 Abbreviations used in this paper: ~2m, ~2-microglobulin; CAT, chloram- 
phenicol acetyltransferase; ER, endoplasmic reticulum; HGH, human 
growth hormone; ISILE, IFN response element; LMP, low molecular mass 
polypeptide; TAP, transporter associated with antigen processing. 
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(B2M) and antigenic peptide (6). This stable trimolecular 
complex is then competent for transport through the Golgi 
apparatus and to the cell surface. The class I bound antigenic 
peptides are derived from degraded endogenous proteins in 
the cytoplasm (7), a process that has been suggested to in- 
volve the 20S proteasome complex (8, 9). The proteasome 
is a multicatalytic, multisubunit complex previously demon- 
strated to be part of the ubiquitin-dependent protein degra- 
dation pathway and is found in all cells studied (10, 11). Two 
recently identified genes, low molecular mass polypeptide 2 
(LMP2) and LMP7, have high homology to the proteasome 
and are located in the MHC class II locus (9, 12, 13). This 
region of the class II locus was initially defined as important 
for class I cell surface expression (14, 15). While early studies 
indicated LMP2 and LMP7 are not essential for antigen pre- 
sentation by class I (16, 17), more recent results suggest that 
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these proteins quantitatively enhance the specificity of the 
proteasome complex by increasing cleavage after hydrophobic 
and basic residues (18-20). This specificity is consistent with 
the characteristics of peptides that are preferentially bound 
by class I molecules (21, 22). Therefore, the LMP molecules 
may increase the availability of specific groups of peptides 
for class I binding. 
Transporter associated with antigen presentation (TAP) 1 
and TAP2 are closely linked to the LMP genes in the MHC 
locus, and share homology with the ATP binding cassette 
family of transporters (14, 23-26). TAP1 and TAP2 form a 
heterodimer (27, 28) that resides in the ER and c/s-Golgi mem- 
branes (29) and transports antigenic peptides into the ER 
lumen for binding by the class I heavy chain (30, 31). The 
TAP heterodimer is critical for class I function since TAP1- 
or TAP2-mutant cell lines lack class I on the cell surface (14, 
24, 32-35). Reconstitution of the TAP heterodimer rescues 
class I surface expression in these cells. Furthermore, trans- 
genic mice deficient in the TAP1 gene also lack class I expres- 
sion on cells and have a severe deficiency in the development 
of cytotoxic T cells (36). The TAP1/TAP2 complex func- 
tions as an ATP-dependent peptide transporter and displays 
some selectivity toward peptides characteristically eluted from 
class I molecules (37). Peptides with a minimum length of 
nine residues and with a hydrophobic COOH-terminal amino 
acid are transported most efficiently (38). A recent study has 
demonstrated that the empty class 1/32M heterodimers 
physically associate with TAP in the ER (39) and then disas- 
sociate from TAP upon peptide binding to class I. This sug- 
gests that TAP may have an additional role in directly loading 
peptide onto class I and/or in retaining empty class 1/32M 
in the ER. Significantly, several studies have shown that some 
tumors and virally infected cells have downregulated TAP ex- 
pression, potentially as a mechanism to lower class I expres- 
sion and escape surveillance by the immune system (40-42). 
Thus, regulation of the TAP genes is critical to the develop- 
ment and integrity of the immune system, while the impor- 
tance of the LMP genes is less clearly defined. 
Analysis of the genomic sequence encompassing the human 
LMP2 and TAP1 genes revealed that these genes would be 
transcribed in a divergent orientation with only 593 bp 
separating the ATG translation initiation codons of the two 
genes (43). The close proximity of the two genes in reverse 
orientation suggested that they might share a common pro- 
moter region. In this report, we describe the coordinate regu- 
lation of the human TAP1 and LMP2 genes. The common 
593-bp intergenic region is sufficient to promote transcrip- 
tion of both TAP1 and LMP2. In vivo genomic footprinting 
and site-directed mutagenesis define a shared Spl-GC box prox- 
imal to the TAP1 gene, which promotes basal level activity 
of both genes. In addition, a shared nuclear factor (NF)-xB 
element coordinately induces both TAP1 and LMP2 upon 
exposure to TNF-cr, a cytokine involved in the upregulation 
of many immune system-related genes. The tight coordinate 
regulation through these elements suggests that the func- 
tions of TAP1 and LMP2 are linked and strengthens the ar- 
gument that the LMP2 gene product also plays an important 
role in the antigen processing pathway. 
Materials and Methods 
Cell Lines. HeLa is a human cervical carcinoma cell line (CCL2; 
American Type Culture Collection, Kockville, MD) grown in 
Eagle's MEM with BSS (Gibco Laboratories, Grand Island, New 
York) supplemented with 10% FCS, 0.1 mM nonessential amino 
acids, 2 mM t-glutamine, and 100 U/ml penicillin and streptomycin. 
The cells were plated at 106 cells per 150 • 25-ram dish every 
other day and maintained at 37~ with 5% CO2. Raji and Na- 
malwa are human EBV-positive Burkitt's lymphoma cell lines, and 
H9, CEM, and Jurkat are human T lymphoblastoid cell lines. All 
lymphoid cell lines were maintained in RPMI 1640 supplemented 
with 8% FCS and 2 mM t-glutamine. U937 is a promyelomono- 
cytic cell line. 
Constructs. The promoterless bidirectional reporter construct, 
HGHCAT, was constructed by cloning the human growth hor- 
mone (HGH) gene, obtained by digestion of pOGH (Nichols In- 
stitute, San Juan Capistrano, CA) with BamHI and EcoRI, into 
the NotI site of pBSCATSK+ (44). Orientation of the insert was 
confirmed by use of a diagnostic digest. The L-HGH/T-CAT and 
the reversed T-HGH/L-CAT constructs were generated by cloning 
the 593-bp LMP2/TAP1 intergenic region into the XbaI site of 
the HGHCAT vector (see Fig. 2 A). The 593-bp insert was ob- 
tained by PCR amplification of a cosmid clone (R4) containing 
the entire genomic region encompassing LMP2 and TAP1, by use 
of two flanking 26-bp primers: PCR1 5'GCTCTAGACCCTGCA- 
AGGCACCGCTC3' and PCR2 5'GCTCTAGATGGCACTCGG- 
ACGCCGTCY. Integrity and orientation of the insert was 
confirmed by sequencing of both strands. The constructs, TlmtGC 
and TlmtKB, were constructed by performing site-directed muta- 
genesis (45) of L-HGH/T-CAT with the following oligonucleo- 
tides: TlmtKB, 5'CAGCCTGTTCCTeG tACTagCCGAGAGCC- 
CCGC 3'; TlmtGC, 5'CGAGAGCCCCaaaCTCGTTCCCTCC 
3'. Deletion constructs are schematically displayed in Figs. 1 B and 
3. Construct names reflect the portion of intergenic promoter re- 
gion retained in the construct and are numbered relative to the 
TAP1 ATG codon. The constructs p461-1TAP and p208-1TAP were 
generated by digestion of L-HGH/T-CAT with unique enzymes 
that cleave within the promoter region (BssHII or NotI, respec- 
tively) and a unique Sinai site within the HGH coding sequence. 
The resulting recircularized deletion constructs have inactivated 
HGH reporter genes and thus can only be assayed for TAP-CAT 
expression. The constructs p593-457LMP and p593-207LMP were 
generated by digestion of L-HGH/T-CAT with unique enzymes 
that cleave within the promoter region (BssHII or NotI, respec- 
tively) and a unique XhoI site within the CAT coding sequence. 
The resulting recircularized deletion constructs have inactivated CAT 
reporter genes and thus can only be assayed for LMP-HGH expres- 
sion. The junctions for all deletion mutants were confirmed by 
sequencing. 
Transfection. All transfections were performed with 15 #g of 
total DNA by the standard CaPO4 protocol (46). To minimize 
sample variability, duplicate DNA precipitates were mixed and then 
half was added to each plate, one for the uninduced and one for 
the TNF-~-induced cells. 10 ng/ml of TNF-c~ (kindly provided 
by Genentech, South San Francisco, CA) were added to the cells 
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when changing the media 4 h after the addition of the DNA precipi- 
tates. Media aliquots and cells were harvested simultaneously 24 h 
later. Cell extracts were prepared and protein content determined by 
the Bradford assay (47). Cell extracts (30 #g) were assayed for chlor- 
amphenicol acetyltransferase (CAT) as previously described (48) and 
quantitated by phospho-imaging (Molecular Dynamics, Sunnyvale, 
CA). Media aliquots for the HGH assay were analyzed by radioim- 
munoassay (Nichols Institute). HGH results were normalized for 
protein concentration to account for differences in cell number. 
Primer Extension and RNAse Protection. Poly A § RNA was 
isolated by use of a modified oligo-dT method (49). HeLa total 
RNA was isolated by use ofKNA STAT-60 (Tel-Test, Friendswood, 
TX). Primer extension analysis of the TAP1 mRNA was performed 
essentially as previously described (50) with a distinct 30-nuchotide 
primer for the endogenous TAP1 mRNA, 5'GCGAGAAGTAGC- 
AGTACTGTCCCCAGCCATY, and a 30-nudeotide primer for the 
transfected TAP1/HGH mKNA, 5'TAGCTAGATGGCACTCGG- 
ACGCCGTCCCGGY. Absolute product lengths were obtained 
by comparison to a sequencing ladder. Position within the pro- 
moter was assigned by use of a value obtained by subtracting the 
size of the coding region 5' to the primer, and the primer size, 
from the absolute product length. RNase protection was performed 
essentially as previously described (50). The template for the syn- 
thesis of RNase protection probes was constructed by inserting 
the 593-bp TAP1/LMP2 promoter fragment obtained by PCR 
amplification into the pCK cloning vector (Invitrogen, San Diego, 
CA). The orientation was confirmed by sequencing. The TAP1 
probe was obtained by in vitro transcription (Promega Corp., 
Madison, WI) directed by the SP6 promoter from the XhoI linear- 
ized template. The LMP2 probe was prepared by in vitro transcrip- 
tion directed by the T7 promoter from the BamHI linearized 
template. 
In vivo Footprinting. In vivo methylation of cells and DNA prep- 
aration were performed as described in Pfeifer et al. (51). The 
ligation-mediated, PCg-amplified in vivo genomic footprinting was 
performed as originally described by Mueller and Wold (52) and 
modified by Wright and Ting (53). Three sets of upper strand 
primers and one set of lower strand primers were used to display 
the TAP1 proximal promoter. The sequences of the upper strand 
primers are as follows: Set I: R412Ap1, 5'AGTCGGCGAGAA- 
GTAGCY; R412Ap2, 5'TGTCCCCAGCCATC~GAGAGAAGCY; 
R412Ap3, 5'TCCCCAGCCATGCGAGAGAAGCTCCGY; Set 2: 
K412Bp1, 5'CATTGGCACTCGGACGCY; R412Bp2, 5'TGA- 
AGCTCCGGGTACCGCCGAGTCY; R412Bp3, 5'TCCGGG- 
TACCGCCGAGTCCTCCCCTACY; Set 3: R412Ep1, 5'CAG- 
CCATGCGAGAGAAGCY; R412Ep2, 5'CTAGAGCTAGCCATT- 
GGCACTCGGACY; R412Ep3, 5'AGCTAGCCATTGGCACTC- 
GGACGCCGY. The sequences of the lower strand primers are as 
follows: Set 3: K124Dp1, 5'TGATTTCCACGCTTGCTACY; 
K124Dp2, 5'ATAGTCTGGGCAGGC CACTTTTGGAAGY; 
K124Dp3, 5'TCTGGGCAGGCCACTTTTGGAAGTAGGCGY. 
Nuclear Extract Preparation and Gel Shift Analysis. Nuclear ex- 
tracts were prepared according to the method of Dignam et al. 
(54) from HeLa cells grown in suspension to a density of 4 x 10 s 
cells/ml. TNF-a-induced extracts were prepared from HeLa cells 
treated with 10 ng/ml TNF-c~ for 15-25 rain before harvest. Gel 
shift analysis was performed as previously described (55). The oli- 
gonucleotides used as probes or competitors are as follows: Tlwt, 
5'GCCTGTTCCTGGGACTTTCCGAGAGCCCCGCCCTCG- 
TTCCCTCCY; TlmtgB, 5'GCCTGTTCCTcGtACTagCCGAGA- 
GCCCCGCCCTCGTTCCCTCCY; TlmtGC, 5'GCCTGTTCC- 
TC_W_;GACTTTCCGAGAGCCCCaaaCTCGTTCCCTCC3'; HIV- 
gB, 5'CTAGACTACAAGGGACTTTCCGCTGGTCTAGY; Sp1 
con, 5'GTCACCGGGGCGGGGCGGTCACY. Antibody super- 
shift experiments were performed by preincubating 1/~g of anti- 
body for 2 h on ice with each binding reaction before the addition 
of the DNA probe. Antibodies were both a kind gift from Dr. 
A. Baldwin (University of North Carolina-Chapel Hill, Chapel 
Hill, NC) and purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA). 
Results 
LMP2 and TAP1 Both Initiate Transcription fiom Multiple Sites 
within a Common Promoter Region. Primer extension and 
RNase protection analysis of messenger KNA obtained from 
several cell lines detected multiple transcription start sites for 
both genes (Fig. 1 A and summarized in Fig. 1 B). The TAP1 
gene initiated from at least 18 different positions within the 
first 120 bp upstream of the TAP1 ATG codon. The presence 
of multiple start sites is consistent with results for other TATA- 
less, GC-rich promoters (56). The 10 most consistent start 
sites found by primer extension of Raji cell mRNA are indi- 
cated in Fig. 1 and were confirmed in two independent ex- 
periments. An additional prominent start site occurs at 
"~ -427 bp. Examination of mRNA from CEM cells con- 
firmed the same pattern of proximal initiation start sites in 
two additional independent primer extension analyses. Only 
the bands that were consistent in all experiments are marked. 
These results were also confirmed by gNase protection anal- 
ysis of mKNA from U937, Jurkat, and HeLa ceUs (data not 
shown). The LMP2 gene uses three major start sites clustered 
at positions -37, -38, and -43 bp relative to the LMP2 
ATG codon in U937 cells. At least 10 other weak LMP2 s tar t  
sites can be detected within the first 100 bp. These results 
were confirmed in five independent experiments and in two 
additional cell lines, HeLa and Jurkat. None of the LMP2 
transcripts overlap any of the TAP1 transcripts, and all of 
the initiation sites for both genes lie within the region be- 
tween the two ATG codons. Therefore, this region could serve 
as a shared bidirectional promoter. 
The Common Promoter Region Is Sufficient to Direct Tran- 
scription in Both Directions. The functionality of the region 
between the two ATG codons was assayed by first cloning 
this region into a bidirectional reporter gene construct. The 
593-bp sequence was amplified by PCR and inserted in ei- 
ther direction between two divergently oriented reporter genes, 
HGH and CAT (Fig. 2 A). The resulting construct when 
transfected into cells allows the simultaneous measurement 
of transcriptional activity in both directions. HGH is secreted 
into the medium and is quantitated by radioimmunoassay, 
while the CAT enzyme is extracted from the harvested cells 
and is quantitated by standard thin-layer chromatography CAT 
enzyme assays. Transfection of HeLa cells with the L-HGH/T- 
CAT construct results in significant transcription in both the 
LMP2 direction (HGH) and the TAP1 direction (CAT) com- 
pared with the promoterless control (Fig. 2/3). Transcrip- 
tion from the reverse construct, T-HGH/L-CAT, also pro- 
duced significant reporter gene expression in both directions. 
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Figure 1. (A) TAP1 and LMP2 genes use multiple transcription start sites. (Left) TAP1 start sites detected by primer extension analysis. Lane 1, 
Raji cell poly A + mRNA (10 #g) primer extended from a TAPl-specific primer. Lane 2, control primer extension of the TAP1 primer with 20/~g 
of tRNA carrier. Prominent bands consistent in all experiments are indicated by arrows, and the position is relative to the TAP1 ATG codon. An 
irrelevant sequencing ladder (lanes G, A, T, and C) was used to accurately size the protected bands. (Right) LMP2 start sites detected by RNase protec- 
tion. Lane 3, U937 cell poly A + mRNA (8 gzg) protected by an LMP2-specific probe. Prominent bands are indicated by arrows and position relative 
to the LMP2 ATG codon. Lane 4, control RNase digestion of the LMP2 probe with 20 ~g of tRNA carrier. A sequence of the LMP2 promoter 
(lanes G, A, T, and C) was used to size the LMP2-protected bands. The probe extended from the TAP1 ATG to the LMP2 ATG with a short segment 
of vector sequence flanking both ends. (B) Sequence of the entire 593-bp intergenic region (43). The ATG translation start codons are indicated by 
a double underline and the gene name. The most prominent transcription start sites determined in A are marked by solid bent arrows for LMP2 and 
open bent arrows for TAP1. The end points of the deletion constructs used in Figs. 3 and 5 are marked by a solid bracket and the name of the construct. 
Shaded boxes mark two functional transcription factor binding sites defined in this report. Open box indicates a potential initiator element (69). Dotted 
underline marks two additional GC boxes, and the solid underline marks the ISRE homology. Numbers along the right side of the figure indicate 
nucleotide numbering from the TAP1 ATG and are used throughout this report except when referring to the LMP2 start sites, which are relative 
to the LMP2 ATG. 
The relative levels of  TAP1 and LMP2 expression can be de- 
termined by comparing CAT expression driven by TAP1 
(I~HGH/T-CAT) with that driven by LMP2 (T-HGH/bCAT)  
or, analogously, H G H  expression driven by either end of  the 
promoter. In both comparisons, TAP1 expression was approx- 
imately threefold higher than LMP2 in HeLa cells. Impor-  
tantly, this analysis also demonstrates that the vector and 
reporter coding sequences do not influence transcription un- 
equally in one direction. Thus, the TAP1 and LMP2 genes 
share a common 593-bp promoter  region, which is sufficient 
to promote bidirectional transcription of both genes. 
Confirmation that the transfected constructs respond in 
a similar manner as the endogenous gene was addressed by 
determining the start sites for the transfected TAP1 gene (Fig. 
2 C).  Primer extension analysis of  R N A  isolated from HeLa 
cells transfected with the T - H G H / b C A T  construct with a 
primer complementary to the H G H  m R N A  sequence de- 
tected multiple initiation sites. Although the experiment is 
arduous, especially in TATA-less promoters, the initiation sites 
correspond well with the endogenous TAP1 initiation sites. 
The relative intensity of  the bands does vary slightly; how- 
ever, no cryptic start sites are detected. This indicates that 
the bidirectional reporter construct is faithfully reproducing 
TAP1 transcription initiation. Primer extension of the LMP2 
transcripts was not successful due to the extremely high G/C  
content of  this region. However, expression of  TAP1 and 
LMP2 was not affected by reversing the promoter  (Fig. 2 B). 
This provides a strong indication that the reporter system 
is not affecting the results and supports further analysis of  
the promoter. 
Deletions from Either End Diminish Transc@tion. The ini- 
tial approach to functionally defining the bidirectional pro- 
moter  was to construct large deletions from either end and 
assay expression in HeLa cells (Fig. 3). For ease of  discussion, 
all deletion points are presented relative to the TAP1 ATG 
translation start codon. Expression of  LMP2 from deletion 
construct p593-207LMP is reduced to only 38% of  wild type 
when "~200 bp are deleted from the TAP1 end. The same 
200 bp proximal to the TAP1 gene are also sufficient to pro- 
mote  transcription in the TAP1 direction (p208-1TAP). This 
indicates that the 207 bp most proximal to the TAP1 gene 
have a critical role in activating distal LMP2 transcription 
as well as the proximal TAP1 gene. TAP1 expression is not 
affected by the inclusion of  sequences up to position 461 (p461- 
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LMP2 .TAP1 T ~ P 2  
B 
Construct CAT HGH 
L-HGH/T-CAT 22.3% (TAP1) 1858 (LMP2) 
%HGH/L-CAT 7.6% (LMP2) 7096 (TAP1) 
HGHCAT 1.2% 0 
T L-~Mp"CAT__ 2.5 _+ .52 
TAPIp-HGH~LM -- 3.3 -+- .66 
Figure 2. The LMP2 and TAP1 intergenic region is sufficient to pro- 
mote divergent transcription of both genes. (.4) Construction of the bi- 
directional reporter plasmids. The 593-bp intergenic region was amplified 
by PCR and cloned into the promoterless bidirectional reporter (HGHCAT) 
in both directions. The prominent transcription start sites as defined in 
Fig. 1 are indicated by solid bent arrows for LMP2 and open bent arrows 
for TAP1. (B) Comparison of expression obtained with CAT and HGH 
as reporters. CAT results are presented as percent acetylation and the HGH 
results are presented as cpm. Results for L-HGH/T-CAT and T-HGH/L- 
CAT are of a representative experiment out of a total of three experiments. 
The ratios of TAP to LMP expression are the averages of two experiments. 
Regardless of the promoter orientation, TAP1 expression was approxi- 
mately threefold higher than LMP2. (C) Transcription start sites from 
the TAP1 promoter of the transfected T-HGH/bCAT construct closely 
parallel endogenous start sites. HeLa cells were transfected as described 
in Materials and Methods, and total RNA was isolated. Start sites were 
identified by primer extension with an HGH-specific primer. Lane 1, con- 
trol tRNA (20/xg); lane 2, transfected HeLa cell RNA (10 #g); lanes 
G, A, T, and C are an irrelevant sequencing ladder for sizing. 
1TAP), indicating that this central region (461-208 bp) is 
not necessary for basal activity of TAP1 transcription. This 
region also does not dramatically affect basal LMP2 expres- 
sion, as demonstrated by the similar levels of activity from 
constructs p593-207LMP and p593-457LMP. The central re- 
gion, however, may be important for induction of  LMP2 
and/or TAP1 transcription, since significant homologies with 
M H C  class I IFN-ol/~ response dements are located in this 
region. The smallest LMP2 construct (p593-457LMP) con- 
tains all of the LMP2 start sites and is sufficient for a low 
level of  LMP2 transcription. However, the LMP2 proximal 
region does not have a major affect on distal TAP1 expres- 
sion (p461-1TAP). These findings reveal that both genes use 
promoter dements located within the TAP1 proximal region. 
In addition, the LMP2 proximal region is also essential for 
LMP2 transcription. 
TAP1-proximal NF-KB and GC Sites Coordinately Regulate 
Basal and TNF-cr-induced Expression of LMP2 and TAPI. The 
deletion studies suggested that the TAPl-proximal region could 
contain shared promoter elements involved in coordinate regu- 
lation of TAP1 and LMP2 expression. D N A  sequence ho- 
mology searches of this region with a transcription factor 
data base indicated the presence of a consensus NF-KB site, 
an adjacent GC box, and an IFN response element (ISKE). 
These sites were obvious candidates for coordinate basal and/or 
induced regulation of TAP1 and LMP2. We initially chose 
to examine basal level regulation by targeting the NF-KB and 
GC elements by site directed mutagenesis (Fig. 4). Mutation 
of the GC box (TImtGC)  significantly reduced transcrip- 
tion in both directions. The GC box was necessary for an 
approximately threefold stimulation of TAP1 expression as 
well as a greater than twofold stimulation of the distal LMP2 
expression. These findings demonstrate an important role for 
the TAPl-proximal GC box in coordinately activating both 
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Figure 3. Deletions from either end diminish transcription. Deletion 
constructs were tramfected into adherent HeLa cells as described in Materials 
and Methods. Results shown for HGH and CAT expression are the av- 
erage of four and eight independent experiments, respectively, with the 
SEM, and have been normalized to the wild-type construct, L-HGH/T- 
CAT. HGH results represent LMP2 transcription and CAT results repre- 
sent TAP1 transcription. The deletion end points are all presented relative 
to the TAP1 ATG translation start codon, and a relative scale is shown 
at the top of the figure. The prominent transcription start sites as defined 
in Fig. 1 are indicated by solid bent arrows for LMP2 and open bent arrows 
for TAP1. NA, not assayed because that reporter was deleted in the construct. 
genes. Mutation of the NF-rB site (TlmtKB) did not alter 
expression of  either gene in the uninduced HeLa cells. This 
result is consistent with the absence of active NF-KB in the 
nucleus of uninduced HeLa cells (57). 
TNF-tx is a potent inducer of  TAP1 expression (58) and 
HLA class I genes (59). However, as yet no published studies 
of  LMP2 regulation by TNF-ot are available. One mecha- 
nism by which TNF-ot exerts its effect on many genes is 
through the activation of the NF-KB transcription factors (60). 
We examined the TAP1 and LMP2 deletion and point muta- 
tion constructs to determine if, upon activation with TNF-ot, 
the putative NF-KB site functions to promote TAP1 and LMP2 
transcription. The wild type promoter  construct (L-HGH/  
T-CAT) is inducible •2.5-fold in both the TAP1 and LMP2 
directions upon T N F - ~  treatment (Fig. 5). All LMP2 in- 
ducibility is lost upon deletion of the TAPl-proximal region 
(p593-207LMP), suggesting that elements proximal to the 
TAP1 gene are required for LMP2 induction. Concordantly, 
the same TAPl-proximal region is sufficient to promote 
TNF-ot induction of TAP1 (p208-1TAP). Mutation of the 
NF-KB site located in this region (TlmtKB) abrogates induc- 
ibility of  both  genes. Interestingly, the adjacent GC box 
(T lmtGC)  is also required for the maximal induction of the 
LMP2 gene but not the proximal TAP1 gene. The effect only 
on the distal gene suggests that the GC box may function 
to amplify the adjacent NF-KB element over larger distances. 
These findings define a central role of  NF-KB in mediating 
TNF-ot induction of TAP1 and demonstrates that LMP2 is 
also regulated by this cytokine. Most importantly, it describes 
conditions of  coordinate and inducible regulation of TAP1 
and LMP2 mediated by identical elements. 
In Vivo Genomic Footprinting Reveals Bound NF-~B and GC 
Boxes at the TAPl-proximal End. Studies of the bidirectional 
reporter constructs dearly defined a functional importance 
for the NF-KB site and G C  box. To directly address the im- 
Figure 4. The TAP proximal GC box is required for both TAP1 and 
LMP2 basal expression. Relative positions of the NF-~B site and the adja- 
cent GC box are indicated by open boxes. Mutated elements are indicated 
by solid boxes. The constructs were assayed in adherent HeLa cells as de- 
scribed in Materials and Methods. Results shown are the averages of six 
independent experiments with the SEM and have been normalized to the 
wild-type construct, L-HGH/T-CAT. 
Figure 5. The NF-KB site is required for TNF-ot induction of TAP1 
and LMP2 expression, and, adjacent to the GC box, is also required for 
LMP2 induction. Black bars indicate TAP1 induction. Shaded bars indi- 
cate LMP2 induction. TNF-cr was added for 24 h to 10 ng/ml. Fold in- 
duction for each construct was determined by dividing the uninduced CAT 
or HGH result by the induced CAT or HGH result, respectively. NA, 
not assayed because the reporter gene was deleted in that construct. The 
result for the deletion mutants, p593-207LMP and p208-1TAP, is the av- 
erage of four and eight independent experiments, respectively. The result 
for the wild-type and site-specific mutants is the average of six indepen- 
dent experiments. Error bars represent the SEM. 
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portance of these sites in transcription of the endogenous genes 
in an intact cell, we examined the in vivo promoter occupancy 
by in vivo genomic footprinting. In vivo genomic footprinting 
reveals the sequences bound by proteins when the genes are 
in their normal in vivo state. This approach therefore delineates 
the in vivo utilized elements and provides information on 
protein/DNA interactions that are physiologically relevant. 
Examination of the TAPl-proximal 200 bp with four sepa- 
rate primer sets revealed no in vivo contacts within the first 
98 bp upstream of the TAP1 initiation codon. However, a 
large cluster of DNA/protein interactions were revealed be- 
tween - 98 and - 146 bp on both the lower strand (Fig. 6) 
and the upper strand (data not shown, summarized in Fig. 
6). The duster of contact points was found in both B lym- 
phoblastoid cell lines (Karl) and T lymphoblastoid cell lines 
(H9). However, the contacts differ slightly between cell lines, 
with the most abundant contacts in the H9 cell line. This 
region contains the NF-KB site and the adjacent GC box as 
well as an additional protected GC box (labeled GC2 box). 
The most consistently bound site in all cells is the GC box, 
which was functionally defined above to be important for 
the expression of both TAP1 and LMP2. Significantly, the 
putative NF-gB site is strongly protected in the H9 cell line 
(Fig. 6), but not at all in the Jurkat cell line (data not shown). 
This corresponds well to the constitutively high levels of 
NF-gB-related subunits found in H9 cells and their virtual 
absence in uninduced Jurkat cells (61). The different pattern of 
NF-gB contacts seen in the B cell line may be indicative 
of different NF-gB subunits present in these cells. Occupancy 
of the GC2 box varies between cell lines examined. The site 
is strongly protected in H9 cells, not at all in Raji cells (Fig. 
6), and weakly in HeLa cells (Fig. 7). Binding at this site 
may have importance in modulating the expression levels in 
different cell types. 
Induction by TNF-ol Alters In Vivo Binding at the NFqcB 
Site. NF-KB is regulated by controlling the ability of the 
active subunits to be transported to the nucleus (62); thus 
induction by TNF-ol would be predicted to alter in vivo 
binding at the TAP1 proximal NF-KB element. We directly 
examined in vivo occupancy at this site in HeLa cells during 
TNF-c~ induction (Fig. 7). Before the addition of TNF-ot, 
HeLa cells show strong contacts on both strands of the TAPl- 
proximal GC box and weak contacts at the GC2 box. In ad- 
dition, there are two enhancements on the lower strand of 
the NF-gB element (lane 1 vs. lane 2 and lane 4 vs. lane 5). 
Treatment with TNF-ot for 15-20 rain resulted in a shift of 
binding at the NF-KB element to two partial protections on 
the lower strand and two additional partial protections on 
the upper strand (lane 2 vs. lane 3 and 5 vs. lane 6). Binding 
at the GC boxes remained unchanged. The weak NF-KB pro- 
tection in vivo is similar to that described previously in the 
Figure 6. In vivo footprint of the TAP1-proximal promoter reveals pro- 
tein/DNA contacts at an NF-~B site and two GC boxes. The lower strand 
in vivo genomic sequence is displayed for the TAPi-proximal region by 
use of primer Set 3 (see Materials and Methods). The upper strand con- 
tacts were revealed with primer Sets I and 2 (data not shown). Raji is 
a B lymphoblastoid cell line. H9 is a T cell line with constitutively high 
NF-~B. cont., in vitro methylated deproteinized DNA; DM$, in vivo meth- 
ylated DNA. Open arrows indicate protections; solid arrows indicate en- 
hancement. Weak protections or enhancements are indicated by open or 
closed arrowheads, respectively. Brackets on the left side of each sequence 
delineate binding site homologies as described in the text and the sequence 
summary. Sequence summary at bottom is marked with the H9 contact 
points. Shaded boxes represent transcription factor binding site homolo- 
gies as indicated in Fig. 1 B 
Figure 7. In vivo binding at the NF-~B element is altered upon TNF-cx 
induction of TAP1 and LMP2 transcription. Lower strand (lanes 1-3) and 
upper strand (lanes 4-6) in vivo genomic sequence of the TAPl-proximal 
promoter from HeLa cells. Lanes 1 and 4, in vitro methylated deproteinized 
DNA; lanes 2 and 5, in vivo methylated DNA from uninduced HeLa ceils; 
lanes 3 and 6, in vivo methylated DNA after a 20-rain TNF-c~ induction. 
The arrows with stars indicate the new protections arising after TNF-c~ 
induction. All other markings are as described in Fig. 6. 
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Figure 8. Sp1 binds the TAPl-proximal GC box, while heterodimers 
of p50/p65 and p52/p65 can bind to the NF-KB element. (A) Gel shift 
analysis of TNF-o~-induced HeLa nuclear extract binding to the TAP1- 
proximal region. Probes are as indicated at the bottom and span the NF- 
KB site and the adjacent GC box (see Materials and Methods). Solid arrows 
mark the bands binding at the GC box; open arrows mark bands binding 
to the NF-KB site. Oligonuchotide competitors were used at ml00-fold 
molar excess and are indicated at the top of the gel. (B) Identity of the 
gel shift bands were confirmed by antibody super-shift analysis. DNA probe 
is as indicated at the bottom, and the antiserum used is marked at the 
top of the gel. Nuclear extract is the same as in A. PI, preimmune sera; 
oep65, o~p50, c~p52, otc-rel, antibodies directed to specific subunits of NF- 
KB; cxSpl, antibody against human transcription factor Spl. 
human invariant chain gene promoter (63). The resulting TAP1 
in vivo binding pattern closely resembles that shown for the 
H9 cell line (Fig. 6), known to have high levels of constitu- 
tive NF-KB activity. These results suggest that TNF-o~ treat- 
ment of HeLa cells induces a change in NF-KB binding, leading 
to a more active transcriptional complex. 
TAPI-proximal NF-KB Site Preferentially Binds p50/p65 and 
p52/p65 Heterodimers While the GC Box Binds Sp1. As a com- 
plement to the in vivo binding studies, we used in vitro gel 
shift analysis to define the protein factors binding to the TAP1- 
proximal promoter elements. A DNA probe spanning the 
NF-KB site and the adjacent GC box revealed one very prom- 
inent band and several weaker bands (Fig. 8 A, lane I ). The 
TAP1 GC box has strong homology to a high-affinity binding 
site for the abundant Spl transcription factor. Oligonucleo- 
tide competition of the wild-type probe with a consensus 
Spl element removes the most prominent band and the fastest 
migrating band (lane 2). This competition reveals two other 
binding activities, labeled KB. Likewise, mutation of the GC 
box allows detection of the same two KB bands (lane 7). These 
two KB bands are specifically competed by a consensus HIV 
NF-KB oligonudeotide but not a consensus Spl element (lanes 
9 and 8, respectively). Thus, two complexes of different mo- 
bility interact with the TAP1 NF-KB site. The two bands 
labeled GC in lane I show specific affinity for the TAP1 GC 
box. The two GC bands bind to the wild-type probe and 
also to a probe mutated in the NF-KB site (lanes 1 and 4). 
Competition of either of these probes with a consensus Spl 
element removes the GC bands, while competition with the 
NF-KB oligonucleotide has no effect (lanes 2 and 5 vs. 3 and 
6). Thus, the TAP1 GC box forms two specific complexes, 
while the NF-KB site forms two additional specific complexes. 
Although the in vivo studies clearly displayed cooccupancy 
of the NF-KB and GC boxes, an in vitro complex containing 
both GC and NF-KB binding activities is not easily discerned 
in these conditions. The diffuse complex migrating slightly 
slower than the prominent GC band is visible only with the 
wild-type probe and is probably the trimolecular complex 
(lane 1 ). In addition, other multicomplexes may be masked 
by the large signal from the upper GC band. 
Antibodies specific for the GC box-binding protein Spl 
or several distinct NF-KB subunits were used to directly assess 
the identity of the proteins bound (Fig. 8 B). The upper prom- 
inent GC band is specifically recognized by antibodies directed 
to Spl, while neither preimmune nor anti-NF-KB-p65 have 
any effect (lanes 1-4). A small amount of upper GC band 
remains after reaction with the anti-Spl antibody and may 
be residual Spl or an antigenically distinct GC box-binding 
protein. The lower GC-specific band did not react with the 
anti-Spl antibody and thus may be a different GC box-binding 
protein. This observation is consistent with previous findings 
of antigenically unrelated Sp1 family members binding in gel 
shift assays (64). The specificity of Spl binding to the TAP1- 
proximal GC boxes was confirmed by DNase I in vitro foot- 
printing. Purified, recombinant Sp1 as well as crude HeLa 
nuclear extract strongly protect the GC box region in a similar 
manner (data not shown). Thus, it is likely that Sp1 is the 
major protein bound at the GC box; however, other GC 
box-binding proteins can not be excluded at this point. 
The panel of NF-KB subunit-specific antibodies shows that 
the lower KB band is diminished by anti-NF-KB-p50 (lane 
7), while the upper band is diminished and partially super- 
shifted by anti-NF-KB-p52 (lane 8). Both the upper and lower 
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bands are diminished by anti-NF-KB-p65 (lane 9), and a su- 
pershifted complex is generated. While the upper band is com- 
pletely abolished by the anti-NF-KB-p65, the lower band is 
only partially diminished. Neither band was recognized by 
the control preimmune sera nor anti-c-tel or anti-Spl (lanes 
6, 10 and 11, respectively). These findings indicate that the 
upper band is composed of p52 and p65 subunits, while the 
lower band is composed at least in part ofpS0 and p65. These 
findings together suggest that Sp1 in conjunction with ei- 
ther NF-KB p50/p65 or p52/p65 bind to the TAPl-proximal 
promoter and mediate transcriptional activation of both TAP1 
and LMP2. 
Discussion 
This report provides the initial characterization of the tran- 
scriptional regulation of the human TAP1 and LMP2 genes. 
Extensive evidence has demonstrated that the MHC class 
II-linked TAP1 and TAP2 gene products are peptide trans- 
porters required to provide peptides to the ER for class I 
binding. Furthermore, the TAP messenger RNAs can be in- 
duced by cytokines consistent with class I expression (1, 24). 
However, no studies on the transcriptional regulation of these 
genes have been published. Interestingly, many tumors and 
virally infected cells downregulate class I, and this phenomenon 
is proposed to allow these cells to escape from immune sur- 
veillance (65). Some of these class I-deficient, vitally infected 
cells clearly have class I mRNA. In addition, some tumors 
have a class I deficiency despite the presence of class I mRNA 
(66). Recently, the TAP1 molecule has been shown to be 
downregulated in some of these tumors, suggesting a mech- 
anism for the loss of class I surface expression (40, 42). It 
will be important to determine if this downregulation occurs 
at the level of transcription or later in synthesis. Although 
no studies have been published regarding the levels of TAP 
in virally infected cells, it will not be surprising to find some 
viruses that also target TAP1 and/or TAP2 to escape immune 
surveillance. Thus, investigations into the regulation of TAP 
gene expression will be critical to the understanding of tumor 
development and, potentially, viral infection. 
The genes for the proteasome complex subunits LMP2 and 
LMP7 are found in the MHC class II locus closely linked 
to the TAP genes. The significance of LMP2 and LMP7 in 
antigen presentation is not as well defined as the TAP genes. 
Cell lines deficient in both LMP genes are still capable of 
antigen presentation. However, a close examination of pep- 
tides produced when LMP2 and LMP7 were present indicated 
a shift in the endopeptidase specificity of the proteasome. The 
characteristics of the resulting peptides are structurally more 
related to those typically bound by class I. The LMP pro- 
teins are found in a subset of the total proteasomes present 
in cells, and their representation can be increased by cytokines 
also responsible for class I upregulation. Thus, LMP2 and 
LMP7 may function to direct the ubiquitous proteasome com- 
plex to directly serve the immune system. The findings pre- 
sented in this report clearly link LMP2 transcription with 
TAP1 transcription and provide additional suggestive evidence 
linking LMP2 to class I antigen presentation. 
The human TAP1 and LMP2 genes are divergently tran- 
scribed with only 593 bp separating the two ATG transla- 
tion initiation codons. The close proximity of the two genes 
suggests coordinate regulation, but this cannot be assumed. 
Several examples of bidirectional discordant regulation have 
been described. The human genes COL4A1 and COL4A2 
are separated by only 127 bp and are divergently transcribed. 
Mutation of several cis-acting elements within the shared re- 
gion has differential effects on the transcription of the two 
genes (67). The divergently arranged H3-II and H3-III his- 
tone genes are also differentially regulated (68). Although 
only 900 bp separate the two genes, each gene has its own 
set of c/s-acting elements, which have no effect on the other 
gene. Therefore, thorough characterization of the c/s-acting 
sequences within the TAP1/LMP2 intergenic region is neces- 
sary to understand the relationship between TAP1 and LMP2 
expression. 
We have shown in this report that the intergenic region 
is sufficient to promote transcription in both directions of 
a bidirectional reporter. The LMP2 gene initiates transcrip- 
tion predominantly from three sites clustered at -40 bp rel- 
ative to the LMP2 ATG codon. This site is occupied in vivo 
(Wright, K. L., unpublished observation) and shows partial 
homology to the initiator element of the erythroid por- 
phobilinogen deaminase gene (69). This is also the predomi- 
nant initiation site of the mouse LMP2 gene (70). The TAP1 
gene uses multiple start sites spread throughout the first 120 
bp relative to the TAP1 ATG codon. An additional start site 
occurs at a far upstream location (~ -427 bp). The upstream 
start site aligns with the major mouse TAP1 transcript; how- 
ever, it has not yet been determined if the mouse TAP1 gene 
also uses the proximal start sites (70). Significantly, there is 
strong homology between mice and humans in this TAP1- 
proximal region. 
The human TAP1 and LMP2 genes are coordinately regu- 
lated by the common use of at least two TAPl-proximal ele- 
ments, an Spl-GC box and NF-KB site. In vivo genomic foot- 
printing revealed that both of these sites are occupied in cells. 
The Spl-GC box upregulates basal transcription of both genes 
two- to threefold. Furthermore, the adjacent NF-KB element 
mediates induction of both TAP1 and LMP2 in response to 
TNF-oe treatment. The Spl-GC box is also required for the 
full induction of the distal LMP2 gene. One possible role 
for the Spl-GC box in this induction is to amplify the effects 
of the adjacent NF-KB site over a greater distance. This would 
be consistent with the observation that the proximal TAP1 
gene requires only the NF-KB site but not the Spl-GC box 
for TNF-oL induction. In addition, in vivo occupancy of the 
Spl-GC box is constitutive, while the NF-KB binding is modu- 
lated on TNF-oe induction. This region is also highly con- 
served in the mouse promoter, with a 7-bp insert between 
the two elements (71). This conservation suggests that the 
mouse genes may also use these sites for coordinate regula- 
tion of TAP1 and LMP2. 
TNF-oe treatment of HeLa cells induces the binding of at 
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least two forms of NF-KB to bind the TAP1 proximal site, 
pS0/p65 and p52/p65. Both of these heterodimers have pre- 
viously been shown to be activators of transcription (72, 73). 
Uninduced HeLa cells contain nuclear pS0/p50 homodimers 
(57), and this may correlate with the distinct pattern of in 
vivo NF-KB occupancy observed on the uninduced TAP1 pro- 
moter. Interestingly, p50/p50 homodimers have been impli- 
cated in repressing transcription (74). However, there may 
be a complex interplay between the NF-KB element and the 
SP1-GC box since mutation of the NF-KB site in the context 
of a wild-type GC box did not significantly increase tran- 
scription. 
TNF-ot is also one of the cytokines that induces class I 
transcription (75). Fine mapping of the class I response ele- 
ment has previously identified a highly conserved NF-KB site 
located in the enhancer A domain (57). The common use 
of NF-KB to induce TAP1 and LMP2 concordantly with class 
I activation suggests a direct mechanism to link transporter 
levels with increases in class I production. Importantly, it 
also provides further credence for a significant role for LMP2 
in the immune response. Likewise, class I and TAP1 are both 
upregulated by IFN-3' (24, 75). The putative ISRE element, 
located in the intergenic promoter (Fig. 1 B), appears to be 
important for upregulation of both LMP2 and TAP1 by IFN-y 
(White, L. C., manuscript in preparation) and could also serve 
to increase transporter levels during the activation of an im- 
mune response. 
These findings now provide a basis to examine the tran- 
scriptional control of TAP1 and LMP2 and have demonstrated 
that these genes are coordinately regulated. Coordinate regu- 
lation of LMP2 with TAP1 is an important finding, suggesting 
a functional linkage between the two gene products and 
thereby placing LMP2 in the class I antigen presentation 
pathway. Furthermore, the study of TAP1 and LMP2 regu- 
lation may enable the design of new strategies to upregulate 
class I during cancer and viral infections. 
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